|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 401 to 450 out of 450 for Nampt

<< First    < Previous  |  Next >    Last >>
0.022s
Type Details Score
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication      
First Author: Bairoch A
Year: 1999
Journal: Database Release
Title: SWISS-PROT Annotated protein sequence database
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication
First Author: Sociali G
Year: 2019
Journal: FASEB J
Title: SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.
Volume: 33
Issue: 3
Pages: 3704-3717
Publication
First Author: Yang S
Year: 2015
Journal: Ann Rheum Dis
Title: NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis.
Volume: 74
Issue: 3
Pages: 595-602
Publication
First Author: Bermudez B
Year: 2017
Journal: Arterioscler Thromb Vasc Biol
Title: Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
Volume: 37
Issue: 6
Pages: 1157-1167
Publication  
First Author: Han S
Year: 2023
Journal: Neurosci Lett
Title: Inhibition of neuronal Kv7 channels ameliorates MK-801-induced cognitive dysfunction in mice via up-regulating NAMPT expression.
Volume: 814
Pages: 137471
Publication
First Author: Menssen A
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.
Volume: 109
Issue: 4
Pages: E187-96
Protein
Organism: Mus musculus/domesticus
Length: 491  
Fragment?: false
Allele
Name: regulatory region 360; targeted mutation 1, Biocytogen LLC
Allele Type: Targeted
Attribute String: Conditional ready, Modified regulatory region
Allele
Name: collagen, type I, alpha 1; targeted mutation 1, Joseph A Baur
Allele Type: Targeted
Attribute String: Conditional ready, Inserted expressed sequence
Allele
Name: nicotinamide phosphoribosyltransferase; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Publication
First Author: Takahashi R
Year: 2010
Journal: J Biochem
Title: Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase.
Volume: 147
Issue: 1
Pages: 95-107
Protein Domain
Type: Domain
Description: This is the N-terminal domain found in Nicotinamide phosphoribosyltransferase (NAMPT) present in Homo sapiens. NAMPT captures nicotinamide (NAM) and replenishes the nicotinamide adenine dinucleotide (NAD+) pool during ADP-ribosylation and transferase reactions [].
Protein Domain
Type: Family
Description: Nicotinamide phosphoribosyl transferase (NAMPT) catalyses the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD [, ]. NAMPT is also known as pre-B cell colony-enhancing factor (PBEF) or visfatin.
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Publication
First Author: Yoo KH
Year: 2021
Journal: Cancer Res
Title: Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments.
Volume: 81
Issue: 13
Pages: 3727-3737
HT Experiment
Series Id: GSE74570
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: ArrayExpress
Protein
Organism: Mus musculus/domesticus
Length: 491  
Fragment?: false
Publication
First Author: Imai S
Year: 2009
Journal: Curr Pharm Des
Title: Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.
Volume: 15
Issue: 1
Pages: 20-8
Publication
First Author: Garten A
Year: 2009
Journal: Trends Endocrinol Metab
Title: Nampt: linking NAD biology, metabolism and cancer.
Volume: 20
Issue: 3
Pages: 130-8
Protein Domain
Type: Domain
Description: Nicotinate phosphoribosyltransferase () is the rate-limiting enzyme that catalyses the first reaction in the NAD salvage synthesis []. Members in this family can be split into two further subfamilies represented in and . Members in have a different (longer) spacing of several key motifs and have an additional C-terminal domain of up to 100 residues. However, one argument suggesting that this family represents the same enzyme is that no species has a member of both subfamilies. Another is that the gene encoding this protein is located near other NAD salvage biosynthesis genes in Nostoc and in at least four different Gram-positive bacteria.Nicotinamide phosphoribosyl transferase (NAMPT) catalyses the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD [, ]. NAMPT is also known as pre-B cell colony-enhancing factor (PBEF) or visfatin.
Publication
First Author: Gilley J
Year: 2015
Journal: Cell Rep
Title: Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
Volume: 10
Issue: 12
Pages: 1974-81
Publication
First Author: Quattrocelli M
Year: 2022
Journal: Sci Adv
Title: Muscle mitochondrial remodeling by intermittent glucocorticoid drugs requires an intact circadian clock and muscle PGC1α.
Volume: 8
Issue: 7
Pages: eabm1189
Publication  
First Author: Shi X
Year: 2021
Journal: Sci Adv
Title: Nuclear NAD+ homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells.
Volume: 7
Issue: 30
Publication
First Author: Nomura M
Year: 2023
Journal: Nat Commun
Title: Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma.
Volume: 14
Issue: 1
Pages: 8095
Publication
First Author: Boshoff HI
Year: 2008
Journal: J Biol Chem
Title: Biosynthesis and recycling of nicotinamide cofactors in mycobacterium tuberculosis. An essential role for NAD in nonreplicating bacilli.
Volume: 283
Issue: 28
Pages: 19329-41
Publication
First Author: Kennaway DJ
Year: 2013
Journal: PLoS One
Title: Global loss of bmal1 expression alters adipose tissue hormones, gene expression and glucose metabolism.
Volume: 8
Issue: 6
Pages: e65255
Publication
First Author: Um JH
Year: 2011
Journal: PLoS One
Title: AMPK regulates circadian rhythms in a tissue- and isoform-specific manner.
Volume: 6
Issue: 3
Pages: e18450
Publication
First Author: Hoizumi M
Year: 2019
Journal: Biochem Biophys Res Commun
Title: Inhibition of GIP signaling extends lifespan without caloric restriction.
Volume: 513
Issue: 4
Pages: 974-982
Publication  
First Author: Morris-Blanco KC
Year: 2016
Journal: Sci Rep
Title: Protein Kinase C Epsilon Promotes Cerebral Ischemic Tolerance Via Modulation of Mitochondrial Sirt5.
Volume: 6
Pages: 29790
Publication
First Author: Locatelli M
Year: 2020
Journal: Sci Rep
Title: Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes.
Volume: 10
Issue: 1
Pages: 8418
Publication
First Author: Tran MT
Year: 2016
Journal: Nature
Title: PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection.
Volume: 531
Issue: 7595
Pages: 528-32
Publication
First Author: Ghosh D
Year: 2014
Journal: Aging Cell
Title: Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons.
Volume: 13
Issue: 4
Pages: 631-40
Publication
First Author: Hiragaki S
Year: 2014
Journal: PLoS One
Title: Melatonin signaling modulates clock genes expression in the mouse retina.
Volume: 9
Issue: 9
Pages: e106819
Publication
First Author: Fletcher RS
Year: 2017
Journal: Mol Metab
Title: Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Volume: 6
Issue: 8
Pages: 819-832
Publication
First Author: Kennaway DJ
Year: 2012
Journal: Obesity (Silver Spring)
Title: Adipokines and adipocyte function in Clock mutant mice that retain melatonin rhythmicity.
Volume: 20
Issue: 2
Pages: 295-305
Publication
First Author: Touat M
Year: 2018
Journal: J Clin Invest
Title: DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.
Volume: 128
Issue: 4
Pages: 1671-1687
Publication
First Author: Inoue T
Year: 2017
Journal: Biochim Biophys Acta
Title: Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways.
Volume: 1862
Issue: 5
Pages: 552-560
Publication
First Author: Heer CD
Year: 2020
Journal: J Biol Chem
Title: Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
Volume: 295
Issue: 52
Pages: 17986-17996
Publication  
First Author: Izadpanah A
Year: 2023
Journal: Front Immunol
Title: SARS-CoV-2 infection dysregulates NAD metabolism.
Volume: 14
Pages: 1158455
Publication
First Author: Yamamoto T
Year: 2014
Journal: PLoS One
Title: Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Volume: 9
Issue: 6
Pages: e98972
Publication
First Author: Brandauer J
Year: 2013
Journal: J Physiol
Title: AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle.
Volume: 591
Issue: 20
Pages: 5207-20
Publication
First Author: Schoggins JW
Year: 2011
Journal: Nature
Title: A diverse range of gene products are effectors of the type I interferon antiviral response.
Volume: 472
Issue: 7344
Pages: 481-5
Publication  
First Author: Costford SR
Year: 2018
Journal: Mol Metab
Title: Skeletal muscle overexpression of nicotinamide phosphoribosyl transferase in mice coupled with voluntary exercise augments exercise endurance.
Volume: 7
Pages: 1-11
Publication  
First Author: Deloux R
Year: 2018
Journal: Front Physiol
Title: Aged Nicotinamide Riboside Kinase 2 Deficient Mice Present an Altered Response to Endurance Exercise Training.
Volume: 9
Pages: 1290
Publication  
First Author: Brouwers B
Year: 2018
Journal: Front Physiol
Title: Elevated Nicotinamide Phosphoribosyl Transferase in Skeletal Muscle Augments Exercise Performance and Mitochondrial Respiratory Capacity Following Exercise Training.
Volume: 9
Pages: 704
Publication  
First Author: Spinelli S
Year: 2021
Journal: Mol Metab
Title: LANCL1 binds abscisic acid and stimulates glucose transport and mitochondrial respiration in muscle cells via the AMPK/PGC-1α/Sirt1 pathway.
Volume: 53
Pages: 101263